﻿<?xml version="1.0" encoding="utf-8"?><!--RSS Genrated: Mon, 06 Apr 2026 19:35:36 GMT--><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:ev="http://purl.org/rss/1.0/modules/event/"><channel><title>American Pharmacists Association</title><link>http://www.pharmacist.com/Publications/Pharmacy-Today/April-2026/rss/4545</link><atom:link href="http://www.pharmacist.com/Publications/Pharmacy-Today/April-2026/rss/4545" rel="self" type="application/rss+xml" /><description>RSS document</description><item><dc:creator><![CDATA[Michelle Powell]]></dc:creator><title><![CDATA[New therapeutic agents marketed in 2025: Part 1]]></title><link>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/new-therapeutic-agents-marketed-in-2025-part-1</link><description><![CDATA[  Mark S. Johnson, PharmD, MACE, BCPS  

   

 FDA approved 46 new (“novel”) drugs in 2025 that had not been approved or marketed in the United States. These new drugs are classified as new ...]]></description><pubDate>Sat, 07 Mar 2026 17:00:00 GMT</pubDate><guid>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/new-therapeutic-agents-marketed-in-2025-part-1</guid><dc:identifier><![CDATA[3fea3d08-a011-4455-a0c4-c8d47a98398c-3867]]></dc:identifier></item></channel></rss>